HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Anton Moritz Ernst Wolner Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grabenwöger, M. Articles by Wolner, E. Search for Related Content PubMed PubMed Citation Articles by Grabenwöger, M. Articles by Wolner, E.

Ann Thorac Surg 1996;62:772-777
© 1996 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Impact of Glutaraldehyde on Calcification of Pericardial Bioprosthetic Heart Valve Material

Department of Cardio-Thoracic Surgery and Zentrum für Biomedizinische Forschung, University of Vienna, Vienna, Austria; and Institute of Histology and Embryology, Veterinary University of Vienna, Vienna, Austria

Accepted for publication April 30, 1996.

Background. This study was conducted to investigate the impact of the preservation method of bioprosthetic heart valve materials on calcification rates and biocompatibility of the biologic tissue.

Methods. In subcutaneous rat implants, conventionally preserved bioprosthetic heart valve material was compared with bovine pericardium that was treated with L-glutamic acid to reduce residual glutaraldehyde released from the fixed tissue. Both these methods were compared with bovine pericardium that was stabilized by a dye-mediated photooxidation reaction without glutaraldehyde. Biocompatibility of these biomaterials was tested in vitro using human endothelial cell cultures.

Results. Conventionally preserved bovine pericardium with a high amount of glutaraldehyde incorporated into the tissue resulted in severe calcification 63 days after subcutaneous implantation in rats (165.4 ± 20 mg Ca²⁺/g dry weight). Postfixation treatment with L-glutamic acid, which reduces free, unbound aldehyde groups, showed a significant decrease in calcification (89.6 ± 14 mg Ca²⁺/g dry weight). Glutaraldehyde-free preservation by dye-mediated photooxidation showed no calcification after 63 days of subcutaneous implantation (1.0 ± 0.4 mg Ca²⁺/g dry weight). Regular endothelial cell proliferation was observed on photooxidized and L-glutamic acid-treated tissue, whereas conventionally treated tissue caused endothelial cell death.

Conclusions. This study underlines the detrimental role of glutaraldehyde in the calcification process of bioprosthetic heart valve materials and emphasizes alternative preservation methods that reduce or avoid the use of glutaraldehyde.

This article has been cited by other articles:

				G. Van Nooten, P. Somers, M. Cornelissen, S. Bouchez, F. Gasthuys, E. Cox, L. Sparks, and K. Narine Acellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV(R) valves in the sheep model Interactive CardioVascular and Thoracic Surgery, October 1, 2006; 5(5): 544 - 549. [Abstract] [Full Text] [PDF]

				F. J. Schoen and R. J. Levy Calcification of Tissue Heart Valve Substitutes: Progress Toward Understanding and Prevention Ann. Thorac. Surg., March 1, 2005; 79(3): 1072 - 1080. [Abstract] [Full Text] [PDF]

				J. M. Connolly, I. Alferiev, J. N. Clark-Gruel, N. Eidelman, M. Sacks, E. Palmatory, A. Kronsteiner, S. DeFelice, J. Xu, R. Ohri, et al. Triglycidylamine Crosslinking of Porcine Aortic Valve Cusps or Bovine Pericardium Results in Improved Biocompatibility, Biomechanics, and Calcification Resistance: Chemical and Biological Mechanisms Am. J. Pathol., January 1, 2005; 166(1): 1 - 13. [Abstract] [Full Text] [PDF]

				M.-T. Kasimir, M. Grabenwoger, P. Boeck, and P. Simon Rapid and untypical calcification of the Sorin pericarbon stentless pericardial xenograft in a child Interactive CardioVascular and Thoracic Surgery, June 1, 2004; 3(2): 370 - 372. [Abstract] [Full Text] [PDF]

				J. M. Gross Calcification of bioprosthetic heart valves and its assessment J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(90030): S6 - 8. [Full Text] [PDF]

				J. M. Gross Calcification of bioprosthetic heart valves and its assessment J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 428 - 430. [Full Text] [PDF]

				K. Jansson, L. Bengtsson, J. Swedenborg, and A. Haegerstrand In vitro endothelialization of bioprosthetic heart valves provides a cell monolayer with proliferative capacities and resistance to pulsatile flow J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0108 - 115. [Abstract] [Full Text] [PDF]

				P. Bonhoeffer, Y. Boudjemline, Z. Saliba, A. O. Hausse, Y. Aggoun, D. Bonnet, D. Sidi, and J. Kachaner Transcatheter Implantation of a Bovine Valve in Pulmonary Position : A Lamb Study Circulation, August 15, 2000; 102(7): 813 - 816. [Abstract] [Full Text] [PDF]

				C. C. Vaughn, P. L. Vaughn, C. C. Vaughn III, P. Sawyer, M. Manning, D. Anderson, L. Roseman, and T. J. Herbst Tissue response to biomaterials used for staple-line reinforcement in lung resection: A comparison between expanded polytetrafluoroethylene and bovine pericardium Eur. J. Cardiothorac. Surg., March 1, 1998; 13(3): 259 - 265. [Abstract] [Full Text] [PDF]